[An elderly man with known heart failure admitted with cardiogenic shock]
- PMID: 20596117
- DOI: 10.4045/tidsskr.09.0384
[An elderly man with known heart failure admitted with cardiogenic shock]
Abstract
A 75-year-old man with post-MI heart failure and an ejection fraction of 15 % was treated with an ACE-inhibitor, spironolactone and a beta-blocker. He had reduced his intake of food and water due to an intercurrent illness the days before admission. He was admitted to our coronary care unit due to bradycardia and hypotension. On arrival his blood pressure was 60/40 mm Hg, and he was in a cardiogenic shock. The electrocardiogram showed broad QRS-complexes and large T waves. Serum-potassium was 9.1 mmol/L and he had acute renal failure with oliguria, probably caused by reduced cardiac output due to hypovolemia combined with taking an ACE inhibitor and spironolactone. Haemodialysis was started and during dialysis QRS complexes became more narrow and heart rate and blood pressure normalized. The patient was discharged 10 days later with normal potassium and creatinine levels. Patients treated with ACE-inhibitors and spironolactone should be monitored closely. During intercurrent illness dehydration may occur and this can lead to renal failure and hyperkalemia which can be life-threatening. The condition should be recognized and addressed promptly, and if indicated haemodialysis should be performed.
Comment in
-
[Hyperkalemia, heart failure and reduced renal function].Tidsskr Nor Laegeforen. 2010 Jul 1;130(13):1354-5. doi: 10.4045/tidsskr.10.0463. Tidsskr Nor Laegeforen. 2010. PMID: 20596118 Norwegian. No abstract available.
Similar articles
-
[Hyperkalemia, heart failure and reduced renal function].Tidsskr Nor Laegeforen. 2010 Jul 1;130(13):1354-5. doi: 10.4045/tidsskr.10.0463. Tidsskr Nor Laegeforen. 2010. PMID: 20596118 Norwegian. No abstract available.
-
Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.Kardiol Pol. 2010 Sep;68(9):1043-5; discussion 1046. Kardiol Pol. 2010. PMID: 20859899
-
[A patient with severe hyperkalaemia -- an emergency after RALES].Dtsch Med Wochenschr. 2005 Sep 9;130(36):2008-11. doi: 10.1055/s-2005-872620. Dtsch Med Wochenschr. 2005. PMID: 16143930 German.
-
Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48. doi: 10.2215/CJN.07821109. Epub 2010 Feb 11. Clin J Am Soc Nephrol. 2010. PMID: 20150448 Review.
-
Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.Am J Med. 2007 Dec;120(12):1090.e1-8. doi: 10.1016/j.amjmed.2007.02.029. Am J Med. 2007. PMID: 18060931 Review.
Cited by
-
Hyperkalemia: A persisting risk. A case report and update on current management.Clin Case Rep. 2020 Jun 2;8(9):1748-1753. doi: 10.1002/ccr3.2974. eCollection 2020 Sep. Clin Case Rep. 2020. PMID: 32983489 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous